大博集团品牌怎么样 申请店铺

我要投票 大博集团在男科医院行业中的票数:148 更新时间:2025-04-03
大博集团是哪个国家的品牌?「大博集团」是 大博医疗科技股份有限公司 旗下著名品牌。该品牌发源于福建省厦门市,由创始人林 * 雄在2004年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力大博集团品牌出海!通过在本页面挂载大博集团品牌的产品链接和联系邮箱,可以提高大博集团产品曝光!跨境电商爆单神器,目前只要100元/年哦~

大博集团怎么样

成立于2004年,以骨科、神经外科、微创外科为主的综合性医疗集团,与世界各地的专家建立良好的合作关系和经验交流


大博简介

大博医疗科技股份有限公司,成立于2004年,坐落于美丽的鹭岛——厦门,是一家以骨科、神经外科、微创外科为主的综合性医疗集团。公司先后通过了FDA、CE、ISO13485、GMP等专业认证,产品品质不断超越国际标准,得到国内外用户的一致认可。

研发制造

紧密结合临床,是大博开展研发工作的基石。经多年的钻研沉淀,与国内北上广等地的知名专家,以及澳大利亚、瑞士等国际专家,皆建立起良好的合作关系,广纳临床专家的实践经验,坚持不懈地进行产品和技术的提升与创新。同时,大博成立了厦门骨科医疗器械工程技术研究中心、与厦门大学联合成立厦大化工——大博医疗外科材料研发中心、同时还与台湾科技大学合办产学研项目,并承接多个科技项目。引进国际加工设备,以高度机械化的生产工艺,依托科学的质量管理体系,精心打造各种医疗产品,涵盖骨科、齿科、微创外科、神经外科、医用电子、医疗设备等。

营销网络

大博在产品、推广、服务等各方面进行创新,在全国多省均设有物流平台,构建便捷的物流网络。与近千家经销商通力合作,不断提高服务效率,及时地为3500余家医院提供优质的服务。同时,大博设立专业的“咨询服务与技术支持”团队,为客户提供医疗器械使用方法及技术要点咨询服务,解决医师在临床上遇到的困难和问题。“高品质,赢天下”。大博放眼全球,实行国际化战略布局,拥有涵盖英语、俄语、拉丁语等多语种的国际营销部门,产品直接出口至澳大利亚、瑞士、俄罗斯、乌克兰等20多个国家和地区。

发展战略

为配合企业前进的步伐,大博制定了四化发展战略:专业化——专攻医疗产品,只做业内前三;多元化——在医疗领域内实现产品多元化,打造综合性医用高值材料供应商;国际化——国际化发展战略,产品研发销售皆面向国际市场;创新化——产品研发、企业发展立足创新,推出创新性医疗产品,坚持以创新驱动发展企业。进行以产品为核心的研发、制造、教育、推广。


Founded in 2004, a comprehensive medical group focusing on orthopedics, neurosurgery and minimally invasive surgery, established a good cooperation relationship and experience exchange with experts from all over the world. Dabo Medical Technology Co., Ltd., founded in 2004, is located in Xiamen, the beautiful island of heron. It is a comprehensive medical group focusing on orthopedics, neurosurgery and minimally invasive surgery. The company has passed FDA, CE, ISO13485, GMP and other professional certification. The product quality continues to exceed international standards, and has been unanimously recognized by users at home and abroad. R & D and manufacturing are closely combined with clinical practice, which is the cornerstone of Dabo's R & D work. After years of research and precipitation, we have established good cooperation with well-known experts in China, Beijing, Shanghai, Guangzhou and other places, as well as international experts in Australia, Switzerland and other places. We have widely accepted the practical experience of clinical experts, and have been unremitting in product and technology upgrading and innovation. At the same time, Dabo has established Xiamen orthopedic medical device engineering technology research center, Xiamen University and Xiamen University to jointly establish Xiamen University chemical - Dabo medical surgical material research and development center. At the same time, Dabo and Taiwan University of science and technology jointly run production, teaching and research projects, and undertake a number of scientific and technological projects. With the introduction of international processing equipment, highly mechanized production process, and relying on scientific quality management system, we have carefully built various medical products, including orthopedics, dentistry, minimally invasive surgery, neurosurgery, medical electronics, medical equipment, etc. The marketing network is innovative in products, promotion, services and other aspects. It has logistics platforms in many provinces across the country to build a convenient logistics network. Cooperate with nearly 1000 distributors to improve service efficiency and provide quality services to more than 3500 hospitals in a timely manner. At the same time, Dabo has set up a professional "consulting service and technical support" team to provide customers with consulting services on the use methods and technical points of medical devices, so as to solve the clinical difficulties and problems encountered by doctors. "High quality, win the world". Dabo has a global perspective and an international strategic layout. It has an international marketing department covering English, Russian, Latin and other languages. Its products are directly exported to more than 20 countries and regions, including Australia, Switzerland, Russia, Ukraine and so on. Development strategy in line with the pace of enterprise progress, Dabo has formulated four development strategies: Specialization - specializing in medical products, only making the top three in the industry; diversification - realizing product diversification in the medical field, creating comprehensive medical high-value material suppliers; internationalization - international development strategy, product R & D and sales are oriented to the international market; innovation - Product R & D Based on innovation, the development of enterprises will launch innovative medical products and adhere to innovation driven development of enterprises. Carry out R & D, manufacturing, education and promotion with products as the core.

本文链接: https://brand.waitui.com/2fe6bfaf5.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

恩捷股份:下属子公司签订锂电池隔离膜供应协议

36氪获悉,恩捷股份公告,下属子公司美国恩捷与美国某知名汽车公司签订《供应协议》,预计2026年至2030年向美国恩捷(及其关联公司)采购约9.73亿平方米的锂电池隔离膜,具体以采购订单为准。该协议自供货起始日起五年内持续有效,将自动续期,每次续期期限为一年。本协议的签订预计将对公司2026年至2030年的经营业绩产生积极影响。

2小时前

欧洲央行会议纪要:政策是否仍然具有限制性已经不再明确

欧洲央行会议纪要显示,通胀的不确定性可能朝任一方向发展,面对不确定性保持谨慎并不一定等同于逐步调整利率。政策是否仍具限制性已不再明确。(财联社)

2小时前

欧佩克+同意在5月进行大于预期幅度的增产

石油输出国组织(欧佩克)4月3日宣布,8个欧佩克和非欧佩克产油国(欧佩克+)当天召开会议,评估全球市场状况与前景。欧佩克+将于5月实施相当于三个月增量、总计41.1万桶/日的产量调整,这一调整包含原定5月的计划增量及额外两个月的增量。(界面)

2小时前

粤传媒:2024营业收入5.97亿元,同比增长6.77%

36氪获悉,粤传媒发布2024年年度报告。报告显示,公司实现营业收入5.97亿元,同比增长6.77%;归属于上市公司股东的净利润为2999.44万元,同比增长258.78%。公司计划每10股派发现金红利0.68元(含税)。

2小时前

美团王兴发布全员信,宣布多项组织调整和人员任命

美团创始人、董事长和首席执行官王兴于4月3日下午发布全员信,宣布原大众点评、SaaS等业务负责人、美团高级副总裁张川转任公司顾问。此外,美团相关组织调整和人员任命如下:第一,点评事业部并入“核心本地商业”,由S-team成员、美团平台负责人李树斌兼任点评事业部负责人。第二,任命原SaaS事业部负责人肖飞担任“软硬件服务”负责人,“软硬件服务”各下属团队汇报给肖飞,肖飞汇报给王兴。(上证报)

2小时前

本页详细列出关于郑州颐和医院的品牌信息,含品牌所属公司介绍,郑州颐和医院所处行业的品牌地位及优势。
咨询